Related Experiment Videos

Parry-Romberg syndrome: follow-up imaging during suppressive therapy

H Goldberg-Stern1, T deGrauw, M Passo

  • 1Department of Neurology, Children's Hospital Medical Center, Cincinnati 45229-3039, USA.

Neuroradiology
|February 11, 1998
PubMed

Insights

Parry-Romberg syndrome, a rare disorder of facial atrophy, can affect the central nervous system. This case study details a child with significant neurological involvement, monitored via MRI, and explores treatment impacts.

Area of Science:

  • Neurology
  • Dermatology
  • Radiology

Background:

  • Parry-Romberg syndrome is a rare, progressive disorder causing unilateral facial atrophy affecting skin, soft tissues, and bone.
  • Central nervous system (CNS) involvement with neurological deficits is an infrequent but serious complication of Parry-Romberg syndrome.

Observation:

  • This report details a pediatric case of Parry-Romberg syndrome with prominent CNS involvement.
  • Serial magnetic resonance imaging (MRI) documented the progression and extent of intracranial lesions.

Findings:

  • The study correlates the clinical presentation and neurological status with radiologic findings in the affected child.
  • The impact of immunosuppressive therapy, specifically prednisone and methotrexate, on the intracranial lesions was investigated.

Implications:

  • This case highlights the importance of considering CNS involvement in Parry-Romberg syndrome, even when facial atrophy is the primary presentation.
  • Understanding the correlation between clinical and radiological findings can guide therapeutic strategies and improve patient outcomes for this rare condition.

Related Concept Videos